Skip to main content

RAS(ON) G12D inhibitor

KRAS G12D is among the most common driver mutations in human cancer and, for a long time, had no direct drug. RAS(ON) inhibitors try to bind the active protein by recruiting cyclophilin A as a partner.

  • RegistryNCT06040541
  • PhasePhase 1
  • StatusRecruiting
  • ConditionKRAS G12D solid tumours
  • SponsorRevolution Medicines
How a RAS(ON) G12D inhibitor worksNCT06040541

The drug

What is being tested.

KRAS is a molecular switch. In the GTP-bound “on” state it drives growth; in the GDP-bound “off” state it does not. G12D locks the switch toward on, and unlike G12C it has no handy cysteine for a covalent drug to grab.

RAS(ON) compounds are molecular glues. They bind cyclophilin A and the active RAS protein at the same time, forming a tri-complex that sterically blocks RAS from signalling through its effectors.

The study

How the trial runs.

The first-in-human studies of RAS(ON) G12D inhibitors enrol adults with advanced solid tumours harbouring KRAS G12D, typically after standard therapy. Dose escalation asks first about safety and pharmacokinetics; expansion cohorts look at particular histologies such as pancreatic and colorectal cancer.

Live record on ClinicalTrials.gov →

Eligibility

Who the study is looking for.

  • Documented KRAS G12D-mutant advanced solid tumour
  • Prior standard therapy, per protocol
  • Adequate organ function and performance status

Inclusion criteria as written on the registry, trimmed. The full list, with exclusions, is on the live record.

For you, or someone you love

Whether or not this trial is the one, bring AI into your corner.

A complex diagnosis brings new questions every week, in a trial and out of one. Triangle keeps your whole medical file together, reads it with you in plain language, and helps you and your family decide what to ask next.

Start your 7-day free trial

Then $9 a month. Cancel anytime.

  • Every record in one place

    Requested from your hospitals and clinics through the national networks. Add scans, pathology and anything on paper.

  • Read in plain words

    Reports explained as they come in, with lab values you can follow before treatment, during a trial and after.

  • Ready for every appointment

    Ask about your own file, and walk in with questions for your oncologist or the trial team.

  • Your people, in the loop

    Share one profile with the family helping you, and with your doctors.

Members also get a deeper analysis of their records and any sequencing data, including clinical trials that may fit, reviewed by a licensed physician before they receive it.

Already in a trial?

It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.

Organize my trial

7-day free trial, then $9 a month. Cancel anytime.

How these trials work: what Phase 1 actually is · common questions Not clinical evidence.